The harms associated with prescription drugs, such as
opioids, stimulants, sedatives and tranquillizers, are a public health and safety concern that has reached crisis proportions in Canada. These harms are felt by individuals, families and communities, as well as by healthcare, social service and public safety systems. The issue has been identified as a priority for action by all levels of government and
many organizations over the past decade.
Joint Statement of Action to Address the Opioid Crisis
Opioid Conference and Summit in November 2016, CCSA joined over 40 other organizations to lay out concrete commitments to bring about the changes required to reduce the harms related to prescription drug misuse in Canada. Those commitments formed the
Joint Statement of Action to Address the Opioid Crisis. CCSA facilitates the sharing of information among signatories to avoid duplication of efforts and encourage collaboration, and
reports on the progress of this collaborative group to the public. View the
annual report, which summarizes the progress accomplished in 2016-2017.
To view, click on the thumbnail above.
Joint Statement of Action commitments
No single organization or level of government working alone can transform the system of care to create the kind of real and lasting change required to address the opioid crisis. Across Canada, organizations and jurisdictions are working collectively to drive impact at the national, jurisdictional and local levels in fulfilling their commitments under the Joint Statement of Action.
Currently, there are 202 commitments being actioned by governments, councils and organizations. This number includes 60
new commitments announced since November 2016 related to alternative pain management, treatment, mental health and addiction, and first responders.
The Joint Statement of Action commitments span prevention, treatment, harm reduction and enforcement, the four pillars of the
Canadian Drugs and Substance Strategy and are supported by a strong evidence base. The activities of each of the signatories can be found
Products of the Opioid Response Partners
Most recent (as of February 1, 2018)
2017 Canadian Guideline for Opioids for Chronic Pain, Michael G. DeGroote National Pain Centre
Access to naloxone across Canada, Canadian Pharmacists Association
Final Report on the AFMC Response to the Canadian Opioid Crisis, Association of Faculties of Medicine of Canada
Opioid-Related Harms in Canada, Canadian Institute for Health Information
Pan-Canadian Trends in the Prescribing of Opioids, 2012 to 2016, Canadian Institute for Health Information
Poster of the 2017 Canadian Opioid Prescribing Guideline, Canadian Medical Association
Reducing the Role of Opioids in Pain Management, Coalition for Safe and Effective Pain Management
Responding to the Opioid Crisis: Leading Practices, Challenges and Opportunities, HealthCareCan
Sink or Swim? Helping Patients and Practitioners to Understand Opioid Potencies and Overdose Risk, Institute for Safe Medication Practices Canada
You can learn more about the Joint Statement of Action commitments and latest progress by attending webinars. Email
email@example.com for more information.